查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386354

阿茲海默症診斷市場報告：2030 年趨勢、預測和競爭分析

Alzheimer's Disease Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

阿茲海默症的趨勢和預測

預計到 2030 年，全球阿茲海默症診斷市場將達到約 54 億美元，2024 年至 2030 年年複合成長率為 7.8%。該市場的主要促進因素是阿茲海默症的盛行率不斷上升、對早期診斷的需求不斷增加以及醫療技術的快速進步。全球阿茲海默症診斷市場前景廣闊，為診所、醫院、診斷中心、製藥公司和學術研究中心帶來未來性。

阿茲海默症診斷市場洞察

Lucintel 預測，大腦影像檢查將在預測期內經歷最高的成長。

由於阿茲海默症的高盛行率和新診斷技術的快速採用，預計北美在預測期內將出現最高的成長。

市場規模/估計：以金額的阿茲海默症診斷市場規模估計（10 億美元）。

趨勢和預測分析：按細分市場和地區分類的市場趨勢（2018-2023）和預測（2024-2030）。

細分分析：按類型、最終用途和地區金額（十億美元）估計阿茲海默症診斷市場規模。

區域分析：北美、歐洲、亞太地區以及世界其他地區、中東和非洲的阿茲海默症診斷市場細分。

成長機會：按類型、最終用途和地區分析阿茲海默症診斷市場的成長機會。

策略分析：阿茲海默症診斷市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球阿茲海默症診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球阿茲海默症診斷市場趨勢（2018-2023）和預測（2024-2030）
  • 按類型分類的全球阿茲海默症診斷市場
    • 神經系統
    • 檢查
    • 基因檢測
    • 輕度精神狀態檢查
    • 腦部影像檢查
  • 全球阿茲海默症診斷市場（按最終用途）
    • 診所
    • 醫院
    • 診斷中心
    • 製藥公司
    • 學術研究中心

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球阿茲海默症診斷市場（按地區）
  • 北美阿茲海默症診斷市場
  • 歐洲阿茲海默症診斷市場
  • 亞太阿茲海默症診斷市場
  • 其他地區阿茲海默症診斷市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球阿茲海默症診斷市場成長機會（按類型）
    • 全球阿茲海默症診斷市場成長機會（按最終用途）
    • 全球阿茲海默症診斷市場按地區成長機會
  • 全球阿茲海默症診斷市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球阿茲海默症診斷市場的能力
    • 全球阿茲海默症診斷市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • AbbVie
  • AC Immune
  • AMARANTUS BIOSCIENCE
  • Anavex Life Sciences
  • Eli Lilly and Company
  • AXON Neuroscience
  • Sio Gene Therapies
簡介目錄

Alzheimer's Disease Trends and Forecast

The future of the global alzheimer's disease diagnostic market looks promising with opportunities in the clinic, hospital, diagnostic center, pharmaceutical company, and academic research center markets. The global alzheimer's disease diagnostic market is expected to reach an estimated $5.4 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of alzheimer's disease, rising demand for early diagnosis, and rapid advancement in healthcare technology.

A more than 150-page report is developed to help in your business decisions.

Alzheimer's Disease by Segment

The study includes a forecast for the global alzheimer's disease by type, end use, and region.

Alzheimer's Disease Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Nervous System
  • Examination
  • Genetic Testing
  • Minor Mental State Examination
  • Brain Imaging Tests

Alzheimer's Disease Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Clinics
  • Hospitals
  • Diagnostic Centers
  • Pharmaceutical Companies
  • Academic Research Centers

Alzheimer's Disease Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Alzheimer's Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies alzheimer's disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the alzheimer's disease companies profiled in this report include-

  • AbbVie
  • AC Immune
  • Amarantus Bioscience
  • Anavex Life Sciences
  • Eli Lilly And Company
  • AXON Neuroscience
  • Sio Gene Therapies

Alzheimer's Disease Diagnostic Market Insights

Lucintel forecasts that brain imaging test is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to high prevalence of alzheimer's disease and rapid adoption of new diagnostic technologies in the region.

Features of the Global Alzheimer's Disease Diagnostic Market

Market Size Estimates: Alzheimer's disease diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Alzheimer's disease diagnostic market size by type, end use, and region in terms of value ($B).

Regional Analysis: Alzheimer's disease diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the alzheimer's disease diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the alzheimer's disease diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the alzheimer's disease diagnostic market size?

Answer: The global alzheimer's disease diagnostic market is expected to reach an estimated $5.4 billion by 2030.

Q.2 What is the growth forecast for alzheimer's disease diagnostic market?

Answer: The global alzheimer's disease diagnostic market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the alzheimer's disease diagnostic market?

Answer: The major drivers for this market are increasing prevalence of alzheimer's disease, rising demand for early diagnosis, and rapid advancement in healthcare technology.

Q4. What are the major segments for alzheimer's disease diagnostic market?

Answer: The future of the alzheimer's disease diagnostic market looks promising with opportunities in the clinic, hospital, diagnostic center, pharmaceutical company, and academic research center markets.

Q5. Who are the key alzheimer's disease diagnostic market companies?

Answer: Some of the key alzheimer's disease companies are as follows:

  • AbbVie
  • AC Immune
  • Amarantus Bioscience
  • Anavex Life Sciences
  • Eli Lilly And Company
  • AXON Neuroscience
  • Sio Gene Therapies

Q6. Which alzheimer's disease diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that brain imaging test is expected to witness highest growth over the forecast period.

Q7. In alzheimer's disease diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of alzheimer's disease and rapid adoption of new diagnostic technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the alzheimer's disease diagnostic market by type (nervous system, examination, genetic testing, minor mental state examination, and brain imaging tests), end use (clinics, hospitals, diagnostic centers, pharmaceutical companies, and academic research centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Alzheimer's Disease Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Alzheimer's Disease Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Alzheimer's Disease Diagnostic Market by Type
    • 3.3.1: Nervous System
    • 3.3.2: Examination
    • 3.3.3: Genetic Testing
    • 3.3.4: Minor Mental State Examination
    • 3.3.5: Brain Imaging Tests
  • 3.4: Global Alzheimer's Disease Diagnostic Market by End Use
    • 3.4.1: Clinics
    • 3.4.2: Hospitals
    • 3.4.3: Diagnostic Centers
    • 3.4.4: Pharmaceutical Companies
    • 3.4.5: Academic Research Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Alzheimer's Disease Diagnostic Market by Region
  • 4.2: North American Alzheimer's Disease Diagnostic Market
    • 4.2.2: North American Alzheimer's Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers
  • 4.3: European Alzheimer's Disease Diagnostic Market
    • 4.3.1: European Alzheimer's Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
    • 4.3.2: European Alzheimer's Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers
  • 4.4: APAC Alzheimer's Disease Diagnostic Market
    • 4.4.1: APAC Alzheimer's Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
    • 4.4.2: APAC Alzheimer's Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers
  • 4.5: ROW Alzheimer's Disease Diagnostic Market
    • 4.5.1: ROW Alzheimer's Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
    • 4.5.2: ROW Alzheimer's Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Alzheimer's Disease Diagnostic Market by Type
    • 6.1.2: Growth Opportunities for the Global Alzheimer's Disease Diagnostic Market by End Use
    • 6.1.3: Growth Opportunities for the Global Alzheimer's Disease Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Alzheimer's Disease Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Alzheimer's Disease Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Alzheimer's Disease Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AbbVie
  • 7.2: AC Immune
  • 7.3: AMARANTUS BIOSCIENCE
  • 7.4: Anavex Life Sciences
  • 7.5: Eli Lilly and Company
  • 7.6: AXON Neuroscience
  • 7.7: Sio Gene Therapies